Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSichuan University
About this trial
The primary aim of this trial is to rigorously evaluate the comparative benefits and potential risks associated with Billroth II reconstruction with Braun anastomosis versus Billroth II reconstruction alone following distal gastrectomy with D2 lymphadenectomy in patients diagnosed with gastric cancer. This assessment focuses on delineating the therapeutic efficacy, safety profile, and overall clinical outcomes of these two surgical approaches in treating this condition.
Eligibility criteria
Qualifiers
Histologically proven stage I-III gastric cancer, evaluated as radically resectable
No synchronous or metachronous cancers
Patients have signed informed consent forms
Age 18-80 years old
Disqualifiers
Pregnant or lactating women
Distant metastasis to the liver, lung, bone, supraclavicular lymph nodes, pelvic, or ovarian species and peritoneal dissemination
Ascites or cachexia
Suffering from other serious diseases, including cardiovascular, respiratory, kidney, or liver disease, poorly controlled hypertension or diabetes
Trial design
Treatments tested in this trial
- Billroth II reconstruction
- Braun Anastomosis
Treatment groups
176 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov